Case Study | Multiple Sclerosis
How AcceleTrial helped a top pharma sponsor exceed site targets for a competitive Multiple Sclerosis trial. 50% of sites completed CDAs and Feasibility Questionnaires in under 7 days.
Identifying 60 sites (40 active, 20 backup) in a highly competitive Multiple Sclerosis therapeutic area.
Executing CDAs and Feasibility Questionnaires with many clinical sites under an accelerated schedule.
Activating sites quickly and efficiently to meet or exceed the sponsor's targeted study timelines.
Using AcceleTrial, LINEA identified 76 pre-qualified MS sites with specific expertise and patient access. 50% of sites completed both CDA and FQ in under 7 days. Rapid FQ turnaround enabled faster overall site selection.
Delivered against a target of 60, providing full activation cohort plus strong backup.
Half of all sites cleared both documents within 7 days, compressing the site selection cycle.
Sponsor activated full target from LINEA's delivery, with 36 additional sites in reserve.